VALVOLINE INC. (VVV) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.63%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.63% | Share-based compensation / revenue. Period ending 2026-06-30. $12.40M ÷ $1.96B × 100 ≈ 0.63% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 1.96B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 12.40M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 301.00M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.96B | $12.40M | $301.00M | (m) | (m) | 0.63% | (m) | (m) |
| 2026-03-31 | (m) | $1.86B | $11.80M | $283.50M | (m) | (m) | 0.63% | (m) | (m) |
| 2025-12-31 | (m) | $1.76B | $10.90M | $264.40M | (m) | (m) | 0.62% | (m) | (m) |
| 2025-09-30 | (m) | $1.71B | $10.50M | $389.90M | (m) | (m) | 0.61% | (m) | (m) |
| 2025-06-30 | (m) | $1.69B | $10.00M | $440.00M | (m) | (m) | 0.59% | (m) | (m) |
| 2025-03-31 | (m) | $1.67B | $11.70M | $438.70M | (m) | (m) | 0.70% | (m) | (m) |
| 2024-12-31 | (m) | $1.66B | $11.60M | $448.20M | (m) | (m) | 0.70% | (m) | (m) |
| 2024-09-30 | (m) | $1.62B | $12.00M | $367.20M | (m) | (m) | 0.74% | (m) | (m) |
| 2024-06-30 | (m) | $1.57B | $12.80M | $302.80M | (m) | (m) | 0.81% | (m) | (m) |
| 2024-03-31 | (m) | $1.53B | $11.70M | $295.90M | (m) | (m) | 0.77% | (m) | (m) |
| 2023-12-31 | (m) | $1.48B | $11.70M | $280.70M | (m) | (m) | 0.79% | (m) | (m) |
| 2023-09-30 | (m) | $1.44B | $12.20M | $247.20M | (m) | (m) | 0.85% | (m) | (m) |
| 2023-06-30 | (m) | $1.39B | $11.50M | $244.20M | (m) | (m) | 0.83% | (m) | (m) |
| 2023-03-31 | (m) | $1.33B | $12.60M | $218.80M | (m) | (m) | 0.95% | (m) | (m) |
| 2022-12-31 | (m) | $1.28B | $14.10M | $197.60M | (m) | (m) | 1.10% | (m) | (m) |
| 2022-09-30 | (m) | $1.24B | $14.40M | $220.30M | (m) | (m) | 1.16% | (m) | (m) |
| 2022-06-30 | (m) | $3.54B | $15.00M | $518.00M | (m) | (m) | 0.42% | (m) | (m) |
| 2022-03-31 | (m) | $3.37B | $15.00M | $511.00M | (m) | (m) | 0.44% | (m) | (m) |
| 2021-12-31 | (m) | $3.19B | $14.00M | $525.00M | (m) | (m) | 0.44% | (m) | (m) |
| 2021-09-30 | $15.00M | $2.98B | $14.00M | $528.00M | (m) | 0.50% | 0.47% | (m) | (m) |
| 2021-06-30 | (m) | $2.80B | $14.00M | $562.00M | (m) | (m) | 0.50% | (m) | (m) |
| 2021-03-31 | (m) | $2.52B | $15.00M | $519.00M | (m) | (m) | 0.59% | (m) | (m) |
| 2020-12-31 | (m) | $2.40B | $11.00M | $505.00M | (m) | (m) | 0.46% | (m) | (m) |
| 2020-09-30 | $13.00M | $2.35B | $12.00M | $485.00M | (m) | 0.55% | 0.51% | (m) | (m) |
| 2020-06-30 | (m) | $2.33B | $9.00M | $422.00M | (m) | (m) | 0.39% | (m) | (m) |
| 2020-03-31 | (m) | $2.43B | $7.00M | $436.00M | (m) | (m) | 0.29% | (m) | (m) |
| 2019-12-31 | (m) | $2.44B | $10.00M | $415.00M | (m) | (m) | 0.41% | (m) | (m) |
| 2019-09-30 | $13.00M | $2.39B | $9.00M | $398.00M | (m) | 0.54% | 0.38% | (m) | (m) |
| 2019-06-30 | (m) | $2.35B | $10.00M | $390.00M | (m) | (m) | 0.42% | (m) | (m) |
| 2019-03-31 | (m) | $2.32B | $10.00M | $390.00M | (m) | (m) | 0.43% | (m) | (m) |
| 2018-12-31 | (m) | $2.30B | $11.00M | $394.00M | (m) | (m) | 0.48% | (m) | (m) |
| 2018-09-30 | $14.00M | $2.29B | $12.00M | $395.00M | (m) | 0.61% | 0.53% | (m) | (m) |
| 2018-06-30 | (m) | $2.24B | $13.00M | $541.00M | (m) | (m) | 0.58% | (m) | (m) |
| 2018-03-31 | (m) | $2.19B | $13.00M | $526.00M | (m) | (m) | 0.59% | (m) | (m) |
| 2017-12-31 | (m) | $2.14B | $12.00M | $526.00M | (m) | (m) | 0.56% | (m) | (m) |
| 2017-09-30 | $13.00M | $2.08B | $9.00M | $532.00M | (m) | 0.62% | 0.43% | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $13.00M | $1.93B | $0.00 | $431.00M | (m) | 0.67% | 0.00% | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $11.00M | $1.97B | $0.00 | $323.00M | (m) | 0.56% | 0.00% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUAKER CHEMICAL CORP (KWR) | United States | $2.747B | 27.94 |